BDP® 650/665 maleimide
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 18480 | 1 mg | $125 | in stock | |
| 28480 | 5 mg | $260 | in stock | |
| 48480 | 25 mg |
$510
|
in stock | |
| 58480 | 50 mg |
$895
|
in stock | |
| 68480 | 100 mg |
$1490
|
in stock |
BDP 650/665 is a bright, red-emitting fluorophore for Cyanine5 (Cy5) channel. The dye has a high molar extinction coefficient and a good emission quantum yield. The dye is moderately hydrophobic but can be used to label biomolecules in an aqueous environment, so it is a good alternative to Cy5.
Maleimide is a thiol-reactive group. The compound can be used for the labeling of cysteine residues of proteins and peptides, among other SH-containing molecules.
Absorption and emission spectra of BDP 650/665
Recommended protocol
Calculator
Customers also purchased with this product
DiI, lipophilic tracer
Orange-red fluorescent lipophilic dye for membrane labeling and cell tracing.ROX maleimide, 5-isomer
ROX maleimide is a thiol reactive dye derivative based on isomerically bright rhodamine X fluorophore.AF 488 NHS ester
AF 488 NHS ester, a bright, photostable, and hydrophilic fluorescent dye for the green channel.General properties
| Appearance: | dark colored solid |
| Mass spec M+ increment: | 555.2 |
| Molecular weight: | 555.34 |
| Molecular formula: | C29H24N5BF2O4 |
| Solubility: | good in DMF, DMSO, low in water |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 649 |
| ε, L⋅mol−1⋅cm−1: | 94000 |
| Emission maximum, nm: | 667 |
| Fluorescence quantum yield: | 0.52 |
| CF260: | 0.04 |
| CF280: | 0.04 |
Product citations
- Massó-Vallés, D.; Beaulieu, M.-E.; Jauset, T.; Giuntini, F.; Zacarías-Fluck, M. F.; Foradada, L.; Martínez-Martín, S.; Serrano, E.; Martín-Fernández, G.; Casacuberta-Serra, S.; Castillo Cano, V.; Kaur, J.; López-Estévez, S.; Morcillo, M. Á.; Alzrigat, M.; Mahmoud, L.; Luque-García, A.; Escorihuela, M.; Guzman, M.; Arribas, J.; Serra, V.; Larsson, L.-G.; Whitfield, J. R.; Soucek, L. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding. Cancer Research Communications, 2022, 2(2), 110–130. doi: 10.1158/2767-9764.CRC-21-0103
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Short link - lumiprobe.com/sh/p/5D
The count of items is incorrect.
Your cart is empty
$ 
